Back to today’s briefing

Story perspectives

UCLA's Nanoparticle Vaccine Revolutionizes Pancreatic Cancer Treatment

3/6/2025

33 2

Summary

Story summary

UCLA researchers have made a groundbreaking advancement in the fight against pancreatic cancer by creating a nanoparticle that merges an mRNA vaccine with an immune-boosting molecule. This innovative treatment not only shrank tumors but also activated immune memory cells. In another promising development, Roche and BioNTech's personalized mRNA vaccine has kept half of its trial participants alive and disease-free after three years.

1 of 1

Story summary

UCLA researchers have made a groundbreaking advancement in the fight against pancreatic cancer by creating a nanoparticle that merges an mRNA vaccine with an immune-boosting molecule. This innovative treatment not only shrank tumors but also activated immune memory cells. In another promising development, Roche and BioNTech's personalized mRNA vaccine has kept half of its trial participants alive and disease-free after three years.